Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Clinical, Biochemical, and Genetic Characteristics of "Nonclassic" Apparent Mineralocorticoid Excess Syndrome.

Tapia-Castillo A, Baudrand R, Vaidya A, Campino C, Allende F, Valdivia C, Vecchiola A, Lagos CF, Fuentes CA, Solari S, Martínez-Aguayo A, García H, Carvajal CA, Fardella CE.

J Clin Endocrinol Metab. 2019 Feb 1;104(2):595-603. doi: 10.1210/jc.2018-01197.

PMID:
30239803
2.

Renal Dysfunction Induced by Kidney-Specific Gene Deletion of Hsd11b2 as a Primary Cause of Salt-Dependent Hypertension.

Ueda K, Nishimoto M, Hirohama D, Ayuzawa N, Kawarazaki W, Watanabe A, Shimosawa T, Loffing J, Zhang MZ, Marumo T, Fujita T.

Hypertension. 2017 Jul;70(1):111-118. doi: 10.1161/HYPERTENSIONAHA.116.08966. Epub 2017 May 30.

3.

Mineralocorticoid excess or glucocorticoid insufficiency: renal and metabolic phenotypes in a rat Hsd11b2 knockout model.

Mullins LJ, Kenyon CJ, Bailey MA, Conway BR, Diaz ME, Mullins JJ.

Hypertension. 2015 Sep;66(3):e20. doi: 10.1161/HYP.0000000000000035. No abstract available.

PMID:
26269656
4.

Mineralocorticoid Excess or Glucocorticoid Insufficiency: Renal and Metabolic Phenotypes in a Rat Hsd11b2 Knockout Model.

Mullins LJ, Kenyon CJ, Bailey MA, Conway BR, Diaz ME, Mullins JJ.

Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. Erratum in: Hypertension. 2015 Sep;66(3):e20.

5.

Role of 11βHSD type 2 enzyme activity in essential hypertension and children with chronic kidney disease (CKD).

Mongia A, Vecker R, George M, Pandey A, Tawadrous H, Schoeneman M, Muneyyirci-Delale O, Nacharaju V, Ten S, Bhangoo A.

J Clin Endocrinol Metab. 2012 Oct;97(10):3622-9. doi: 10.1210/jc.2012-1411. Epub 2012 Aug 7.

PMID:
22872687
6.

Licorice: a sweet alternative to prevent hyperkalemia in dialysis patients?

Ferrari P.

Kidney Int. 2009 Oct;76(8):811-2. doi: 10.1038/ki.2009.282.

7.

Glycyrrhetinic acid food supplementation lowers serum potassium concentration in chronic hemodialysis patients.

Farese S, Kruse A, Pasch A, Dick B, Frey BM, Uehlinger DE, Frey FJ.

Kidney Int. 2009 Oct;76(8):877-84. doi: 10.1038/ki.2009.269. Epub 2009 Jul 29.

8.

Genetics of the kidney and hypertension.

Watson B Jr.

Curr Hypertens Rep. 2003 Jun;5(3):273-6. Review.

PMID:
12724062
9.

Acute intrarenal administration of cortisol has no effect on renal blood flow in hypertensive individuals.

van Uum SH, Houben AJ, Hermus AR, Kroon AA, Walker BR, Sweep CG, Smits P, de Leeuw PW, Lenders JW.

J Hypertens. 2002 Nov;20(11):2275-83.

PMID:
12409967
10.

Increased cortisol metabolites and reduced activity of 11beta-hydroxysteroid dehydrogenase in patients on hemodialysis.

N'Gankam V, Uehlinger D, Dick B, Frey BM, Frey FJ.

Kidney Int. 2002 May;61(5):1859-66.

11.

Structural analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene in end-stage renal disease.

Zaehner T, Plueshke V, Frey BM, Frey FJ, Ferrari P.

Kidney Int. 2000 Oct;58(4):1413-9.

12.

A new polymorphic restriction site in the human 11 beta-hydroxysteroid dehydrogenase type 2 gene.

Smolenicka Z, Bach E, Schaer A, Liechti-Gallati S, Frey BM, Frey FJ, Ferrari P.

J Clin Endocrinol Metab. 1998 May;83(5):1814-7.

PMID:
9589699

Supplemental Content

Loading ...
Support Center